BSX लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:01):

Stats
आज की मात्रा	938 875
औसत मात्रा	6.57M
बाजार मूल्य	107.03B
EPS	$0 ( 2024-04-24 )
अगली कमाई की तारीख	( $0.580 ) 2024-07-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	61.19
ATR14	$0.0740 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Sorenson John Bradley	Buy	16 351	Common Stock
2024-04-01	Sorenson John Bradley	Sell	16 351	Common Stock
2024-04-01	Sorenson John Bradley	Sell	16 351	Stock Option (Right to Buy)
2024-04-01	Carruthers Wendy	Buy	1 197	Common Stock
2024-04-01	Carruthers Wendy	Buy	3 066	Common Stock

INSIDER POWER
-44.36
Last 100 transactions
Buy: 127 379 \| Sell: 329 771

मात्रा सहसंबंध

लंबा: 0.16 (neutral)

छोटा: -0.27 (neutral)

Signal:(49.808) Neutral

Boston Scientific Corp सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
SQSP	0.94
DTC	0.934
CANE	0.931
HCHC	0.931
CRD-B	0.93
SGG	0.928
KOF	0.928
OR	0.927
IBA	0.926
RELX	0.924

10 सबसे अधिक नकारात्मक सहसंबंध
CBU	-0.94
SFUN	-0.923
ASPN	-0.907
TUP	-0.907
SCHW	-0.902
NBHC	-0.902
JP	-0.897
NIC	-0.897
EVA	-0.889
ARIS	-0.887

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Boston Scientific Corp सहसंबंध - मुद्रा/वस्त्र

0.63
( weak )

0.66
( moderate )

0.00
( neutral )

-0.29
( neutral )

-0.03
( neutral )

-0.81
( strong negative )

Boston Scientific Corp वित्तीय

Annual	2023
राजस्व:	$14.24B
सकल लाभ:	$9.90B (69.49 %)
EPS:	$1.080

FY	2023
राजस्व:	$14.24B
सकल लाभ:	$9.90B (69.49 %)
EPS:	$1.080

FY	2022
राजस्व:	$12.68B
सकल लाभ:	$8.68B (68.44 %)
EPS:	$0.450

FY	2021
राजस्व:	$11.89B
सकल लाभ:	$8.13B (68.37 %)
EPS:	$0.730

Financial Reports:

No articles found.

Boston Scientific Corp

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.